BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30551735)

  • 1. Inventory of oncologists' unmet needs for tools to support decision-making about palliative treatment for metastatic colorectal cancer.
    Engelhardt EG; Révész D; Tamminga HJ; Punt CJA; Koopman M; Onwuteaka-Philipsen BD; Steyerberg EW; de Vet HCW; Coupé VMH
    BMC Med Inform Decis Mak; 2018 Dec; 18(1):132. PubMed ID: 30551735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Usefulness of Tools to Support Decision-making for Palliative Treatment of Metastatic Colorectal Cancer: A Systematic Review.
    Engelhardt EG; Révész D; Tamminga HJ; Punt CJA; Koopman M; Onwuteaka-Philipsen BD; Steyerberg EW; Jansma IP; De Vet HCW; Coupé VMH
    Clin Colorectal Cancer; 2018 Mar; 17(1):e1-e12. PubMed ID: 28734786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Needs with Regard to Decision Support Systems for Treating Patients with Incurable Non-small Cell Lung Cancer.
    Révész D; Engelhardt EG; Tamminga JJ; Schramel FMNH; Onwuteaka-Philipsen BD; van de Garde EMW; Steyerberg EW; de Vet HCW; Coupé VMH
    J Cancer Educ; 2020 Apr; 35(2):345-351. PubMed ID: 30685832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients' Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist's Awareness of These Preferences.
    Oostendorp LJ; Ottevanger PB; van de Wouw AJ; Honkoop AH; Los M; van der Graaf WT; Stalmeier PF
    J Cancer Educ; 2016 Sep; 31(3):443-8. PubMed ID: 25985960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How accurate are medical oncologists' impressions of management of metastatic colorectal cancer in Australia?
    Au L; Turner N; Wong HL; Field K; Lee B; Boadle D; Cooray P; Karikios D; Kosmider S; Lipton L; Nott L; Parente P; Tie J; Tran B; Wong R; Yip D; Shapiro J; Gibbs P
    Asia Pac J Clin Oncol; 2018 Apr; 14(2):e167-e174. PubMed ID: 28299879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What Is Important When Making Treatment Decisions in Metastatic Breast Cancer? A Qualitative Analysis of Decision-Making in Patients and Oncologists.
    Rocque GB; Rasool A; Williams BR; Wallace AS; Niranjan SJ; Halilova KI; Turkman YE; Ingram SA; Williams CP; Forero-Torres A; Smith T; Bhatia S; Knight SJ
    Oncologist; 2019 Oct; 24(10):1313-1321. PubMed ID: 30872466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decision support systems for incurable non-small cell lung cancer: a systematic review.
    Révész D; Engelhardt EG; Tamminga JJ; Schramel FMNH; Onwuteaka-Philipsen BD; van de Garde EMW; Steyerberg EW; Jansma EP; De Vet HCW; Coupé VMH
    BMC Med Inform Decis Mak; 2017 Oct; 17(1):144. PubMed ID: 28969629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment recommendations within the leeway of clinical guidelines: A qualitative interview study on oncologists' clinical deliberation.
    Otte I; Salloch S; Reinacher-Schick A; Vollmann J
    BMC Cancer; 2017 Nov; 17(1):780. PubMed ID: 29162047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (SAKK 95/06).
    Strasser F; Blum D; von Moos R; Cathomas R; Ribi K; Aebi S; Betticher D; Hayoz S; Klingbiel D; Brauchli P; Haefner M; Mauri S; Kaasa S; Koeberle D;
    Ann Oncol; 2016 Feb; 27(2):324-32. PubMed ID: 26646758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community Oncologists' Decision-Making for Treatment of Older Patients With Cancer.
    Mohile SG; Magnuson A; Pandya C; Velarde C; Duberstein P; Hurria A; Loh KP; Wells M; Plumb S; Gilmore N; Flannery M; Wittink M; Epstein R; Heckler CE; Janelsins M; Mustian K; Hopkins JO; Liu J; Peri S; Dale W
    J Natl Compr Canc Netw; 2018 Mar; 16(3):301-309. PubMed ID: 29523669
    [No Abstract]   [Full Text] [Related]  

  • 11. How do oncologists make decisions about chemotherapy for their older patients with cancer? A survey of Australian oncologists.
    Moth EB; Kiely BE; Naganathan V; Martin A; Blinman P
    Support Care Cancer; 2018 Feb; 26(2):451-460. PubMed ID: 28776149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncologists' Views on Using Value to Guide Cancer Treatment Decisions.
    Gidwani-Marszowski R; Nevedal AL; Blayney DW; Patel M; Kelly PA; Timko C; Ramchandran K; Murrell SS; Asch SM
    Value Health; 2018 Aug; 21(8):931-937. PubMed ID: 30098670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-line treatment choices of Turkish medical oncologists in metastatic colorectal cancer: A survey study.
    Beypinar I; Araz M; Uysal M; Yalcin S
    J BUON; 2019; 24(1):68-76. PubMed ID: 30941953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy treatment decision-making experiences of older adults with cancer, their family members, oncologists and family physicians: a mixed methods study.
    Puts MT; Sattar S; McWatters K; Lee K; Kulik M; MacDonald ME; Jang R; Amir E; Krzyzanowska MK; Leighl N; Fitch M; Joshua AM; Warde P; Tourangeau AE; Alibhai SM
    Support Care Cancer; 2017 Mar; 25(3):879-886. PubMed ID: 27830393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-reported use of shared decision-making among breast cancer specialists and perceived barriers and facilitators to implementing this approach.
    Charles C; Gafni A; Whelan T
    Health Expect; 2004 Dec; 7(4):338-48. PubMed ID: 15544686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ONCOLOGISTS' BARRIERS AND FACILITATORS FOR ONCOTYPE DX USE: QUALITATIVE STUDY.
    Roberts MC; Bryson A; Weinberger M; Dusetzina SB; Dinan MA; Reeder-Hayes K; Wheeler SB
    Int J Technol Assess Health Care; 2016 Jan; 32(5):355-361. PubMed ID: 27958190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Evaluation of a Real-World Outcomes-Based Tool to Support Informed Clinical Decision Making in the Palliative Treatment of Patients With Metastatic NSCLC.
    Cramer-van der Welle CM; Kastelijn EA; Plouvier BC; van Uden-Kraan CF; Schramel FMNH; Groen HJM; van de Garde EMW
    JCO Clin Cancer Inform; 2021 May; 5():570-578. PubMed ID: 34010031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncologists' End of Life Treatment Decisions.
    Bluhm M; Connell CM; Janz N; Bickel K; DeVries R; Silveira M
    J Appl Gerontol; 2017 Apr; 36(4):416-440. PubMed ID: 26198272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chinese oncologists' knowledge, attitudes and practice towards palliative care and end of life issues.
    Gu X; Cheng W
    BMC Med Educ; 2016 May; 16():149. PubMed ID: 27188161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.